Menu-Photo
Tafasitamab-Cxix: Benefits, Reviews, Info, Side Effects!
Rx Details
Tafasitamab-Cxix
MOR208, XmAb5574
Tafasitamab
2019
Prescription
Drug
Drugs
Prescription Only
Available
Tafasitamab-cxix is a monoclonal antibody used in the treatment of certain types of lymphoma. Here are some of its benefits: – Targets CD19 antigen on B-cells – Used in combination with lenalidomide – Treats relapsed or refractory diffuse large B-cell lymphoma (DLBCL) – Provides an option for patients ineligible for autologous stem cell transplant – Can lead to durable responses – Offers a targeted therapy approach – Administered intravenously Please consult a healthcare professional for detailed information and advice specific to individual health needs.
Cough, Decreased Appetite, Diarrhea, Fatigue, Fever, Rash, Respiratory Tract Infection, Swelling Of Lower Legs Or Hands
Tafasitamab-cxix, marketed under the brand name Monjuvi, is a monoclonal antibody used in the treatment of certain types of lymphoma. The dosage of tafasitamab-cxix can vary based on the specific treatment regimen and the patient’s condition. Typically, it is administered in combination with lenalidomide for the treatment of relapsed or refractory diffuse large B-cell lymphoma (DLBCL). The usual dosing schedule for tafasitamab-cxix is as follows: – **Cycle 1 (Days 1 to 28):** 12 mg/kg administered intravenously on Days 1, 4, 8, 15, and 22. – **Cycle 2 and 3 (Days 29 to 84):** 12 mg/kg administered intravenously on Days 1, 8, 15, and 22. – **Cycle 4 and beyond (Days 85 and onward):** 12 mg/kg administered intravenously on Days 1 and 15. It’s important to note that this is a general guideline, and the actual dosage and schedule may vary based on individual patient factors and the prescribing physician’s judgment. Always consult a healthcare professional for specific medical advice and treatment plans.
Tafasitamab-cxix is commonly used to treat diffuse large b-cell lymphoma.
Tafasitamab-Cxix has a favorable safety profile.
No interactions found
$10,000 – $15,000
$13,000 for a 400 mg vial.

A Synopsis of

Tafasitamab-Cxix

Tafasitamab-Cxix is a novel monoclonal antibody that has shown promising results in the treatment of certain types of lymphoma. This drug works by targeting a specific protein on the surface of cancer cells, which helps to inhibit their growth and spread.

Clinical trials have demonstrated that Tafasitamab-Cxix can be effective in patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL), a type of non-Hodgkin lymphoma. In these studies, patients who received Tafasitamab-Cxix in combination with other chemotherapy agents experienced improved response rates and overall survival compared to those who received chemotherapy alone.

As with any medication, Tafasitamab-Cxix does come with potential side effects. Common side effects may include infusion reactions, low blood cell counts, fatigue, and infections. It is important for patients to discuss these potential side effects with their healthcare provider before starting treatment.

It is crucial for patients to follow their healthcare provider’s instructions carefully when taking Tafasitamab-Cxix. This may include receiving regular blood tests to monitor for any potential side effects and adjusting the dosage as needed.

Overall, Tafasitamab-Cxix represents a promising new option for patients with certain types of lymphoma. As a medical professional, I recommend discussing the potential benefits and risks of this medication with your healthcare provider to determine if it is the right treatment option for you.

What'd you think of this RX?

Subscribe
Notify of
guest

0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments

PAGE LAST UPDATED

  • Post Views: 1872
0
Would love your thoughts, please comment.x
()
x